Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers.
about
Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Phase I Clinical Study of ZYAN ...... tration in Healthy Volunteers.
@en
Phase I Clinical Study of ZYAN ...... tration in Healthy Volunteers.
@nl
type
label
Phase I Clinical Study of ZYAN ...... tration in Healthy Volunteers.
@en
Phase I Clinical Study of ZYAN ...... tration in Healthy Volunteers.
@nl
prefLabel
Phase I Clinical Study of ZYAN ...... tration in Healthy Volunteers.
@en
Phase I Clinical Study of ZYAN ...... tration in Healthy Volunteers.
@nl
P2093
P2860
P1476
Phase I Clinical Study of ZYAN ...... tration in Healthy Volunteers.
@en
P2093
Chintan Y Shah
Deven Parmar
Hardik B Patel
Harilal V Patel
Heather Heading
Jason Lickliter
Kevinkumar A Kansagra
Kinjal Barot
Krupi V Parmar
Maulik R Patel
P2860
P2888
P304
P356
10.1007/S40262-017-0551-3
P577
2017-05-16T00:00:00Z
P6179
1085424583